| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | AQST Aquestive Therapeutics, Inc. | Schobel Alexander Mark83 | Chief Innovation/ Tech Officer | Sell | 25,000 | $5.19 | $129,685.00 | -2.3% | -42.4% | -45.7% | |
| Mar 8, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 10,000 | $67.17 | $671,700.00 | -1.2% | +2.1% | -10.1% | |
| Mar 8, 2024 | ELAN Elanco Animal Health Inc | Doyle William F53 | Director | Buy | 15,000 | $16.30 | $244,500.00 | +32.4% | +11.1% | -32.3% | |
| Mar 8, 2024 | ELAN Elanco Animal Health Inc | Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50,493.73 | +4.2% | +11.1% | -32.3% | |
| Mar 8, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 30,000 | $241.07 | $7,232,240.60 | -22.3% | +13.7% | +30.0% | |
| Mar 8, 2024 | PCRX Pacira Biosciences, Inc. | Pace Gary W66 | Director | Sell | 119,323 | $30.64 | $3,656,226.39 | -30.3% | -7.3% | -25.6% | |
| Mar 8, 2024 | ANIP Ani Pharmaceuticals Inc | Lalwani Nikhil66 | President &CEO | Sell | 45,257 | $66.10 | $2,991,468.76 | -5.0% | +2.1% | -10.1% | |
| Mar 7, 2024 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Sell | 15,348 | $0.23 | $3,603.71 | -0.2% | - | - | |
| Mar 7, 2024 | ANIP Ani Pharmaceuticals Inc | Marken James G.47 | SVP Ops &Prod Dev | Sell | 24,338 | $66.37 | $1,615,313.06 | -16.4% | +0.4% | -9.1% | |
| Mar 7, 2024 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $237.38 | $1,424,309.07 | -5.0% | +15.3% | +31.7% | |
| Mar 7, 2024 | MRMD Marimed Inc. | Levine Jon R | President And CEO | Sell | 16,529 | $0.23 | $3,881.01 | - | - | - | |
| Mar 7, 2024 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 18,023 | $61.96 | $1,116,705.08 | -14.8% | +31.8% | +69.9% | |
| Mar 7, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Patel Sanj K | Chairman &CEO | Sell | 65,012 | $21.02 | $1,366,552.24 | -100% | -7.3% | +1.2% | |
| Mar 7, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 2,747 | $14.19 | $38,979.93 | -100% | +51.6% | +150.5% | |
| Mar 7, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 40,000 | $65.77 | $2,630,863.64 | -1.5% | +0.4% | -9.1% | |
| Mar 7, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 35,253 | $14.19 | $500,106.61 | -1.1% | +51.6% | +150.5% | |
| Mar 6, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 18,136 | $46.48 | $842,883.11 | -5.1% | -8.8% | -38.8% | |
| Mar 6, 2024 | IRWD Ironwood Pharmaceuticals Inc | Duane Jon R | Director | Buy | 6,920 | $8.70 | $60,204.00 | +6.1% | -24.4% | -82.0% | |
| Mar 6, 2024 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 20,000 | $16.14 | $322,808.00 | +12.1% | +13.4% | -32.5% | |
| Mar 6, 2024 | LNTH Lantheus Holdings, Inc. | Lantheus Alpha Therapy, LLC | 10% Owner | Buy | 60,431,039 | $0.95 | $57,409,487.05 | +107.3% | +31.5% | +61.7% | |
| Mar 6, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 21,300 | $234.68 | $4,998,678.79 | -22.2% | +15.3% | +29.8% | |
| Mar 6, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 77,550 | $13.52 | $1,048,119.27 | -27.6% | +22.9% | +13.5% | |
| Mar 6, 2024 | LNTH Lantheus Holdings, Inc. | Leno Sam R | Director | Sell | 4,090 | $64.06 | $262,004.99 | -1.4% | +31.5% | +61.7% | |
| Mar 6, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Patel Sanj K | Chairman &CEO | Sell | 18,324 | $21.34 | $391,055.86 | -8.0% | -8.0% | +1.3% | |
| Mar 6, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 100,000 | $0.08 | $7,500.00 | +9.0% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.